Svensson, T., Chowdhury, O., Garelius, H., Lorenz, F., Saft, L., Jacobsen, S., . . . Cherif, H. (2014). A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.
Cytowanie według stylu Chicago (wyd. 17)Svensson, T., O. Chowdhury, H. Garelius, F. Lorenz, L. Saft, SE Jacobsen, E. Hellström-Lindberg, i H. Cherif. A Pilot Phase I Dose Finding Safety Study of the Thrombopoietin-receptor Agonist, Eltrombopag, in Patients with Myelodysplastic Syndrome Treated with Azacitidine. 2014.
Cytowanie według stylu MLA (wyd. 9)Svensson, T., et al. A Pilot Phase I Dose Finding Safety Study of the Thrombopoietin-receptor Agonist, Eltrombopag, in Patients with Myelodysplastic Syndrome Treated with Azacitidine. 2014.